Free tool
MEDI and FSPHX: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between MEDI and FSPHX
40% of their top holdings overlap by weight, with 11 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that FSPHX holds far more positions (152 vs 44), so it is broader beyond the top names.
| Holding | % of MEDI | % of FSPHX |
|---|---|---|
| Eli Lilly & Co | 20.78% | 8.03% |
| Ascendis Pharma A/S | 13.61% | 2.17% |
| Gilead Sciences Inc | 5.10% | 2.21% |
| AbbVie Inc | 3.09% | 2.03% |
| Cencora Inc | 2.75% | 1.14% |
| Merck & Co Inc | 2.47% | 1.60% |
| Boston Scientific Corp | 2.40% | 2.17% |
| Natera Inc | 2.26% | 1.27% |
| Argenx SE | 2.07% | 1.56% |
| Danaher Corp | 1.73% | 6.89% |
| UnitedHealth Group Inc | 1.39% | 3.49% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized